Pentair’s Return on Invested Capital Overview

According to Benzinga Pro, during Q1, Pentair (NYSE:PNR) earned $129.70 million, a 36.53% increase from the preceding quarter.…

According to Benzinga Pro, during Q1, Pentair (NYSE:PNR) earned $129.70 million, a 36.53% increase from the preceding quarter. Pentair also posted a total of $1.03 billion in sales, a 2.59% increase since Q4. Pentair earned $95.00 million, and sales totaled $1.00 billion in Q4.

Why Is ROIC Significant?

Earnings data without context is not clear and can difficult to base trading decisions on. Return on Invested Capital (ROIC) helps to filter signal from noise by measuring yearly pre-tax profit relative to invested capital by a business. Generally, a higher ROIC suggests successful growth of a company and is a sign of higher earnings per share in the future. In Q1, Pentair posted an ROIC of 3.46%.

It is important to keep in mind that ROIC evaluates past performance and is not used as a predictive tool. It is a good measure of a company’s recent performance, but does not account for factors that could affect earnings and sales in the near future.

ROIC is a powerful metric for comparing the effectiveness of capital allocation for similar companies. A relatively high ROIC shows Pentair is potentially operating at a higher level of efficiency than other companies in its industry. If the company is generating high profits with its current level of invested capital, some of that money can be reinvested in more capital which will generally lead to higher returns and, ultimately, earnings per share (EPS) growth.

For Pentair, the positive return on invested capital ratio of 3.46% suggests that management is allocating their capital effectively. Effective capital allocation is a positive indicator that a company will achieve more durable success and favorable long-term returns.

Upcoming Earnings Estimate

Pentair reported Q1 earnings per share at $0.91/share, which beat analyst predictions of $0.77/share.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Amicus Therapeutics Reports Preliminary 2023 Revenue And Provides 2024 Strategic Outlook; Q4 Revenue ~$115.1M Vs $112.25M Est.; Sees FY23 Revenue Of ~$399.4M Vs $396.45M Est.; Co Sees FY24 As First Full Year Of Achieving Non-GAAP Profitability

Bradley Campbell, President and Chief Executive Officer of Amicus Therapeutics, Inc., stated, "Last year was an incredible year for Amicus highlighted by the continued double-digit growth of Galafold sales and the global

FOLD

Read More

Analysts Weigh In On Applied Materials Earnings Print: What Investors Need To Know

Semiconductor equipment provider Applied Materials, Inc (NASDAQ: AMAT) beat the Street's expectations for its fiscal first quarter. The Santa Clara, California-based company issued upbeat guidance for the current quarter. As a result, several prominent analysts issued notes on the stock.

AMAT